Perfil
Ms. Hema Keshava is a Senior Vice President-Finance at Abivax SA and a Corporate Controller at CinCor Pharma, Inc.
Cargos activos de Hema Keshava
| Empresas | Cargo | Inicio |
|---|---|---|
| CINCOR PHARMA, INC. | Comptroller/Controller/Auditor | 01/11/2021 |
| ABIVAX | Corporate Officer/Principal | 01/07/2023 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ABIVAX | Health Technology |
| Empresas privadas | 1 |
|---|---|
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Hema Keshava
